Nicotine is a major psychoactive and addictive component of tobacco. Although cessation of tobacco use produces various somatic and affective symptoms, withdrawal-related cognitive deficits are considered to be a critical symptom that predict relapse. Therefore, delineating the cognitive mechanisms of nicotine withdrawal may likely provide gainful insights into the neurobiology of nicotine addiction. The present study was designed to examine the effects of nicotine withdrawal induced by mecamylamine, a nonspecific nicotinic receptor (nAChR) antagonist, on cognitive control processes in mice using an operant strategy switching task. Brain-derived neurotrophic factor (BDNF) modulates synaptic transmission in frontostriatal circuits, and these circuits are critical for executive functions. Thus, we examined the effects of mecamylamine-precipitated nicotine withdrawal on prefrontal and striatal BDNF protein expression. Mice undergoing precipitated nicotine withdrawal required more trials to attain strategy switching criterion as compared to the controls. Error analysis indicated that impaired performance in these animals was mostly related to their inability to execute the new strategy. The striatal/prefrontal BDNF ratios robustly increased following precipitated nicotine withdrawal. Moreover, higher BDNF ratios were associated with longer task acquisition. Collectively, our findings illustrate that mecamylamineinduced nicotine withdrawal disrupts cognitive control processes and that these changes are possibly linked to perturbations in frontostriatal BDNF signaling.
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Nicotine addiction is a global health problem and smokingrelated illness reigns atop the causes of preventable death worldwide. Even though chronic nicotine exerts very little positive effects on mood and motor/cognitive performance as opposed to other drugs of abuse (Epping-Jordan, Watkins, Koob, & Markou, 1998; Risner & Goldberg, 1983) , smokers continue to consume cigarettes presumably to alleviate unpleasant withdrawal-related physiological/affective symptoms and to restore activity in brain reward pathways (Johnson, Hollander, & Kenny, 2008; Miyata & Yanagita, 2001) . Despite the availability of treatments for smoking cessation that mostly focus on normalizing the reward function and motivational/affective components of nicotine addiction, relapse to smoking after quit attempts still remains very high (Gonzales et al., 2006; Hughes, Peters, & Naud, 2008) . Because of the extensive overlap between cognitive and reward-/ motivation-related brain processes, chronic drug-induced neuroadaptive changes and possible interactions between these processes are proposed to underlie compulsive drug use (Everitt et al., 2008; Gould, 2010) . Moreover, nicotine withdrawal-related cognitive deficits are hypothesized to predict relapse (Ashare, Falcone, & Lerman, 2014) . Therefore, delineation of cognitive mechanisms that determine higher rates of relapse during nicotine withdrawal is likely to provide gainful insights into the neurobiology of nicotine addiction.
Loss of cognitive control in drug addicts is primarily manifested as the inability to change responding to stimuli previously associated with drug stimulus or reward, and deficits in cognitive flexibility are critical in triggering drug craving and relapse (Stalnaker, Takahashi, Roesch, & Schoenbaum, 2009; Volkow et al., 2010) . Although the effects of nicotine withdrawal on reward/motivation and contextual learning are well studied, how it affects cognitive flexibility and what cellular mechanisms are responsible for the effects are not known. Brain-derived neurotrophic factor (BDNF) plays an important role in activitydependent regulation of synaptic function, cognition, affect and conditioned reward (Chao, 2003; Lu, Christian, & Lu, 2008; Nestler & Carlezon, 2006) . BDNF gene polymorphism has been linked to nicotine dependence (Lee, Anastasia, Hempstead, Lee, & Blendy, 2015) . Moreover, frontostriatal circuits involving discrete regions of the prefrontal cortex (PFC) and dorsal striatum are implicated in decision-making (Balleine, Delgado, & Hikosaka,
